| Cancer chemopreventive activity of resveratrol, a natural product derived from grapes M Jang, L Cai, GO Udeani, KV Slowing, CF Thomas, CWW Beecher, ... science 275 (5297), 218-220, 1997 | 6747 | 1997 |
| Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid GO Udeani, C Gerhäuser, CF Thomas, RC Moon, JW Kosmeder, ... Cancer research 57 (16), 3424-3428, 1997 | 170 | 1997 |
| Novel strategies for the discovery of plant-derived anticancer agents AD Kinghorn, NR Farnsworth, DD Soejarto, GA Cordell, JM Pezzuto, ... Pure and Applied Chemistry 71 (9), 1611-1618, 1999 | 131 | 1999 |
| Pharmacokinetics and tissue distribution of betulinic acid in CD‐1 mice 1 GO Udeani, GM Zhao, Y Geun Shin, BP Cooke, J Graham, CWW Beecher, ... Biopharmaceutics & drug disposition 20 (8), 379-383, 1999 | 107 | 1999 |
| Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats GO Udeani, GM Zhao, YG Shin, JW Kosmeder Ii, CWW Beecher, ... Cancer chemotherapy and pharmacology 47, 263-268, 2001 | 60 | 2001 |
| Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients C Kalani, E Awudi, T Alexander, G Udeani, S Surani Hospital practice 47 (4), 181-185, 2019 | 37 | 2019 |
| Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy BJ Donald, S Surani, HS Deol, UJ Mbadugha, G Udeani Drug Design, Development and Therapy, 3559-3566, 2017 | 31 | 2017 |
| Sepsis patients in critical care units with obesity: is obesity protective? C Kalani, T Venigalla, J Bailey, G Udeani, S Surani Cureus 12 (2), 2020 | 29 | 2020 |
| Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia KS Kaye, G Udeani, P Cole, HD Friedland Hospital Practice 43 (3), 144-149, 2015 | 28 | 2015 |
| Long-acting verapamil and heart failure SK Mohindra, GO Udeani Jama 261 (7), 994-994, 1989 | 28 | 1989 |
| A review of respiratory biologic agents in severe asthma N Johnson, B Varughese, A Marianne, SR Surani, G Udeani, S Surani Cureus 11 (9), 2019 | 26 | 2019 |
| Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience A Ramani, G Udeani, J Evans, A Jandourek, P Cole, A Smith, ... Journal of Chemotherapy 26 (4), 229-234, 2014 | 21 | 2014 |
| Drug-induced liver injury and prospect of cytokine based therapy; A focus on IL-2 based therapies N Kumar, S Surani, G Udeani, S Mathew, S John, S Sajan, J Mishra Life Sciences 278, 119544, 2021 | 19 | 2021 |
| Role of clinical pharmacists in intensive care units E Arredondo, G Udeani, M Horseman, TD Hintze, S Surani, MI Horseman Cureus 13 (9), 2021 | 18 | 2021 |
| Omecamtiv mecarbil: a novel mechanistic and therapeutic approach to chronic heart failure management PH Patel, M Nguyen, R Rodriguez, S Surani, G Udeani Cureus 13 (1), 2021 | 17 | 2021 |
| Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections in obese patients JD Evans, G Udeani, P Cole, HD Friedland Postgraduate medicine 126 (5), 128-134, 2014 | 15 | 2014 |
| Inhibition of granulocyte colony stimulating factor (G-CSF) adsorption to polyvinyl chloride using a nonionic surfactant PL Wang, GO Udeani, TP Johnston International journal of pharmaceutics 114 (2), 177-184, 1995 | 15 | 1995 |
| Review of the management of obstructive sleep apnea and pharmacological symptom management L Panahi, G Udeani, S Ho, B Knox, J Maille Medicina 57 (11), 1173, 2021 | 14 | 2021 |
| Treatment of massive pulmonary embolism with centrally administered tissue-type plasminogen activator. SK Mohindra, GO Udeani Annals of emergency medicine 22 (8), 1349-1352, 1993 | 14 | 1993 |
| Implementation of pharmacogenomics and artificial intelligence tools for chronic disease management in primary care setting P Silva, D Jacobs, J Kriak, A Abu-Baker, G Udeani, G Neal, K Ramos Journal of Personalized Medicine 11 (6), 443, 2021 | 13 | 2021 |
